| - GRCh37:
- Chr20:21687184
- GRCh38:
- Chr20:21706546
| PAX1 | R132Q | Otofaciocervical syndrome 2 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr20:21689917
- GRCh38:
- Chr20:21709279
| PAX1 | S373A | Otofaciocervical syndrome 2 | Uncertain significance (Jan 13, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:21686545-21686546
- GRCh38:
- Chr20:21705907-21705908
| PAX1 | A67fs | Otofaciocervical syndrome 2, not provided | Conflicting interpretations of pathogenicity (Jul 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:21686508
- GRCh38:
- Chr20:21705870
| PAX1 | S53* | Otofaciocervical syndrome 2, not provided | Conflicting interpretations of pathogenicity (Mar 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:21690006-21690007
- GRCh38:
- Chr20:21709368-21709369
| PAX1 | G405fs | Otofaciocervical syndrome 2, not provided | Conflicting interpretations of pathogenicity (Jan 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr20:21689246
- GRCh38:
- Chr20:21708608
| PAX1 | W323R | Otofaciocervical syndrome 2, not provided | Uncertain significance (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:21689975
- GRCh38:
- Chr20:21709337
| PAX1 | P392R | not provided, Otofaciocervical syndrome 2 | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:21687600
- GRCh38:
- Chr20:21706962
| PAX1 | P271A | Otofaciocervical syndrome 2, not provided | Uncertain significance (Jul 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:21687228
- GRCh38:
- Chr20:21706590
| PAX1 | V147L | Otofaciocervical syndrome 2 | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr20:21687250-21687252
- GRCh38:
- Chr20:21706612-21706614
| PAX1 | N155del | Otofaciocervical syndrome 2 | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr20:21689265
- GRCh38:
- Chr20:21708627
| PAX1 | T329R | Otofaciocervical syndrome 2 | Uncertain significance (Dec 7, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr20:21686445
- GRCh38:
- Chr20:21705807
| PAX1 | A32V | not provided, Otofaciocervical syndrome 2 | Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:21689981
- GRCh38:
- Chr20:21709343
| PAX1 | P394L | Otofaciocervical syndrome 2, Inborn genetic diseases, not provided
| Uncertain significance (Jan 26, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr20:21689904
- GRCh38:
- Chr20:21709266
| PAX1 | C368* | Otofaciocervical syndrome 2 | Pathogenic (Jun 15, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr20:21689967-21689968
- GRCh38:
- Chr20:21709329-21709330
| PAX1 | P392fs | Otofaciocervical syndrome 2 | Likely pathogenic (Jan 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr20:21687286
- GRCh38:
- Chr20:21706648
| PAX1 | G166V | not provided | Pathogenic (Sep 7, 2022) | criteria provided, single submitter |